Hikma Pharmaceutical | HIK - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Almirall EUR 323.65M 26.99M 2026-06
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Autolus Therapeutics Ltd USD 63.6M 9.84M 2026-03
Bayer EUR 33.46B 875M 2026-03
Fresenius EUR 9.07B 468M 2026-06
Genmab DKK 1.14B 38M 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
GRIFOLS EUR 2.24B 112M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lakefront Biotherapeutics EUR 100.42M 52.44M 2026-03
Lonza CHF 3.57B 421M 2025-12
Merck EUR 9.35B 307M 2026-03
Orion EUR 454.5M 344.1M 2026-06
Recordati EUR 1.4B 30.88M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
UCB EUR 4.4B 470M 2025-12